EQT
59
2
TDC
75
4
EXPE
88
2
L
62
2
IPG
49
10
PVH
52
-3
CF
59
3
PRU
57
-3
UPS
41
-4
SRE
63
-3
CAH
47
3
CVX
46
5
EIX
77
2
PPL
54
2
VLO
40
-2
AMP
69
-3
DG
2
-6
AFL
46
-3
AIG
38
-4
HOG
29
-4
EQT
59
2
TDC
75
4
EXPE
88
2
L
62
2
IPG
49
10
PVH
52
-3
CF
59
3
PRU
57
-3
UPS
41
-4
SRE
63
-3
CAH
47
3
CVX
46
5
EIX
77
2
PPL
54
2
VLO
40
-2
AMP
69
-3
DG
2
-6
AFL
46
-3
AIG
38
-4
HOG
29
-4
Financhill
Back

Roche Holding AG 10K Form

Sell
26

RHHBY
Roche Holding AG

Last Price:
35.13
Seasonality Move:
-0.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RHHBY News And Ratings

See the #1 stock for the next 7 days that we like better than RHHBY

RHHBY Financial Statistics

Sales & Book Value

Annual Sales: $67.31B
Cash Flow: $0
Price / Cash Flow: 18.09
Annual Sales: $5.05
Price / Book: 7.06

Profitability

EPS (TTM): 1.84540
Net Income (TTM): $11.84B
Gross Margin: $49.09B
Return on Equity: 32.32%
Return on Assets: 11.53%

Roche Holding AG Earnings Forecast

Key Roche Holding AG Financial Ratios

  • The Gross Profit Margin over the past 26 years for RHHBY is 72.94%.
  • The Selling, General & Administrative Expenses for RHHBY have been equal to 24.62% of Gross Profit Margin.
  • The Research & Development expenses have been 23.49% of Revenue.
  • The Interest Expense is 8.67% of Operating Income.
  • The Net Earning history of RHHBY is 19.02% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 15 years.

Roche Holding AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RHHBY
Website: roche.com

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 1.26
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 17.91
Forward P/E Ratio: 11.75

RHHBY Technical Analysis vs Fundamental Analysis

Sell
26
Roche Holding AG (RHHBY) is a Sell

Is Roche Holding AG a Buy or a Sell?

  • Roche Holding AG stock is rated a Sell
    The current Roche Holding AG [RHHBY] share price is $35.13. The Score for RHHBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.